Post-approval studies (Phase 4)UnknownNCT02710747
What this trial is testing
The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.
Who this might be right for
Heart Valve DiseaseOlder Than 18-years-oldWithout Any Liver or Kidney Diseases
Guangdong Provincial People's Hospital 500